Lenox Wealth Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-49
Closed -$4K 761
2019
Q3
$4K Buy
+49
New +$4.66K ﹤0.01% 574
2019
Q1
Sell
-55
Closed -$4K 725
2018
Q4
$4K Hold
55
﹤0.01% 506
2018
Q3
$5K Sell
55
-96
-64% -$8.48K ﹤0.01% 515
2018
Q2
$12K Sell
151
-39
-21% -$3.24K ﹤0.01% 354
2018
Q1
$16K Sell
190
-97
-34% -$9.31K 0.01% 324
2017
Q4
$30K Sell
287
-87
-23% -$9.82K 0.01% 273
2017
Q3
$54K Buy
374
+42
+13% +$5.72K 0.02% 210
2017
Q2
$43K Buy
+332
New +$40.7K 0.02% 219

Other funds holding CELG

Lenox Wealth Management's CELG Position: Q4 2019 in Review

Lenox Wealth Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 49 shares — an estimated $4K sold.

Lenox Wealth Management first reported a position in CELG in Q2 2017 and held it in 8 quarters. The position peaked at $54K in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Lenox Wealth Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Lenox Wealth Management sold 49 Celgene Corp shares in Q4 2019, an estimated $4K.
  • Lenox Wealth Management first reported a position in Celgene Corp in Q2 2017 and held it in 8 quarters.
  • Lenox Wealth Management's Celgene Corp position peaked at $54K in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Lenox Wealth Management's 13F filing for Q4 2019, filed 29 Jan 2020.